Log in to save to my catalogue

Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobact...

Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobact...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d0a10c29dfa14460a3f70f4590528fe0

Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobacter cloacae complex

About this item

Full title

Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobacter cloacae complex

Publisher

England: BioMed Central Ltd

Journal title

BMC microbiology, 2022-11, Vol.22 (1), p.284-284, Article 284

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Enterobacter cloacae complex (ECC) is a common opportunistic pathogen and is responsible for causing various infections in humans. Owing to its inducible chromosomal AmpC β-lactamase (AmpC), ECC is inherently resistant to the 1st- and 2nd- generation cephalosporins. However, whether β-lactams antibiotics enhance ECC resistance remains unclear.
I...

Alternative Titles

Full title

Cefazolin and imipenem enhance AmpC expression and resistance in NagZ-dependent manner in Enterobacter cloacae complex

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_d0a10c29dfa14460a3f70f4590528fe0

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_d0a10c29dfa14460a3f70f4590528fe0

Other Identifiers

ISSN

1471-2180

E-ISSN

1471-2180

DOI

10.1186/s12866-022-02707-7

How to access this item